In this free webinar, learn about technology solutions to forecast study requirements, accounting for diversity data. Attendees will gain insights into the role of telemedicine and remote monitoring in enabling participation. The featured speakers will discuss how applying new innovative trial designs, like virtual and mobile sites, can broaden patient access. The speakers also will share how decentralized solutions, such as wearables/sensors, home healthcare services, pharmacy networks and micro-sampling technology are improving accessibility. Attendees also will gain insights into the new FDA guidance around decentralized clinical trials (DCT) and patient diversity plans.
TORONTO, Aug. 28, 2023 /PRNewswire-PRWeb/ -- In today's rapidly evolving healthcare landscape, the need for clinical trial diversity and inclusivity has become a regulatory imperative. However, traditional recruitment methods often fall short in reaching underrepresented populations, leading to a lack of diversity in clinical research studies. This webinar aims to explore how technology can be harnessed to overcome barriers to clinical trial participation and create more inclusive clinical trials.
Join this webinar as the featured speakers delve into the potential of technology to revolutionize the recruitment and retention process today and in the future, ensuring that clinical trials are representative of the diverse patient populations they aim to serve. The expert panel of industry leaders will share their insights, experiences and success stories in leveraging technology to help drive clinical trial health equity.
This webinar highlights the transformative power of technology in clinical trials, enabling accurate study requirements, diverse applications and optimized protocols for patient populations. It emphasizes the patient-centric approach, reducing burdens on participants and staff. Telemedicine and innovative trial designs overcome geographical challenges, enhancing patient engagement. Decentralized solutions foster inclusivity, bringing trials to patients' homes. Ethical considerations are explored, and the latest U.S. Food and Drug Administration (FDA) guidance on decentralized trials and patient diversity plans are covered, empowering attendees to confidently navigate the regulatory landscape.
Register now to learn how clinical trial diversity and inclusivity can be improved through the use of telemedicine decentralized solutions and other technologies.
Join the following experts from Thermo Fisher Scientific's PPD clinical research business: Rose Blackburne, MD, MBA, VP and Global Head of General Medicine & Women's Health; Jennifer Urwongse, DCT Strategy and Innovation Director; and Julie Hockett, Feasibility Strategist, for the live webinar on Wednesday, September 20, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Clinical Trial Diversity: Harnessing the Power of Technology for More Inclusive Studies.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article